17 Jan 2018

SENATE COMMITTEE APPROVES ALEX AZAR TO HEAD HHS

The U.S. Senate Finance Committee voted 15-12 to approve the nomination of Alex Azar to be the next Secretary of the Department of Health and Human Services (HHS) Jan. 17. Only one Democrat, Tom Carper of Delaware, assented to Azar’s nomination, joining the panel’s Republicans. The committee vote sets up

0
15 Jan 2018

3D-PRINTED LIVING BIOINK CAN FORM “LIVING TATTOOS”

  Researchers at MIT have developed a living bioink for 3D printing that consists of genetically-modified bacteria and a synthetic hydrogel. The material can be printed in a variety of shapes, including as patches or “tattoos” for the skin, and can sense different chemicals, along with changes in pH and

0
12 Jan 2018

CENTERLINE BIOMEDICAL  COMPLETES FIFTH STUDY ON IOPS SURGICAL NAVIGATION SYSTEM AT CLEVELAND CLINI

  Endovascular navigation startup Centerline Biomedical has successfully completed a fifth preclinical study at Cleveland Clinic facilities to see how its surgical navigation system, the Intra-Operative Positioning System (IOPS), will perform in the marketplace. The study demonstrated its ability to track IOPS instruments precisely and efficiently with enhanced three-dimensional (3D) visualization and

0
12 Jan 2018

COOK GROUP EXPANDS BY BUYING ADJACENT VACANT GE SITE

  Cook Group, through its subsidiary Cook Properties, has agreed to purchase the former GE site near Cook’s world headquarters in Bloomington, Ind. Cook Group is expanding its medical device business into the vacant GE property on Curry Pike. This purchase allows Cook the flexibility to address some immediate space

0
12 Jan 2018

BECTON, DICKINSON COMPLETES ACQUISITION OF C.R. BARD

Becton, Dickinson (BD) has completed the acquisition of C.R. Bard, creating a new healthcare company with approximately $16 billion in annualized revenue. Vincent A Forlenza, chairman and CEO, said the combined company builds on BD’s position in medication management and infection prevention with an expanded offering of solutions across the care

0
11 Jan 2018

PRISM TRIAL EVALUATES SAFETY, EFFICACY OF INDIGO ASPIRATION SYSTE

Results of the multicenter PRISM trial were published by Richard R. Saxon, MD, et al in the  Journal of Vascular and Interventional Radiology (JVIR; 2018;29:92–100). PRISM evaluated the safety and initial efficacy of a power aspiration–based extraction technique for treatment of peripheral arterial thromboembolism using the Indigo aspiration system from Penumbra Inc.. The JVIR investigators

0
11 Jan 2018

FDA APPROVES XABLECATH BLUNT TIP SUPPORT CATHETER

  XableCath’s blunt tip support catheter has received clearance from the U.S. Food and Drug Administration (FDA). In two clinical investigator-led studies, the device was demonstrated to be a safe, effective, and easy-to-use device, enabling therapeutic options for patients with PAD,” said Johannes Dahm, MD and director of Interventional Cardiology

0
06 Jan 2018

STUDY SHOWS STEM CELL TRANSPLANT IS BETTER THAN DRUG THERAPY FOR SCLERODERMA

Photo courtesy of American College of Rheumatology   Adding irradiation before transplant improves long-term results and should change practice    Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an

0
15 Dec 2017

AMERICAN VEIN & VASCULAR INSTITUTE ADDS NEW PHYSICIAN

John Joseph Randono, MD, has joined the phlebology staff of American Vein & Vascular Institute, a network of eight vein and arterial diagnosis and treatment centers in Colorado and Texas. Dr. Randono has more than 30 years medical experience, specifically as a cardiac and thoracic vascular surgeon, and as a

0
11 Dec 2017

4 DOCTORS AMONG 20 CHARGED WITH BILKING MEDICARE, MEDICAID AND OTHER MANAGED CARE ORGANIZATIONS OUT OF $146 MILLION

Twenty people — four of whom are doctors — are facing charges related to a massive fraud scheme that bilked Medicare, Medicaid and other managed care organizations out of $146 million. Prosecutors from the Brooklyn District Attorneys Office said the defendants ran an enterprise in which recruiters offered cash to low-income and

0